ATS Corporation Q2 2025 Earnings Call Summary

ATS Corporation (Ticker: ATS) reported its second quarter fiscal 2025 earnings results on November 6, 2024, revealing a mixed performance. Despite a 17% year-over-year revenue drop to $613 million primarily due to weaker transportation sales, the company achieved record bookings in its Life Sciences division. The robust order backlog is over $1.8 billion, with Life Sciences contributing a record of $1.1 billion, up 32% from the previous year.

ATS anticipates revenue growth in the upcoming quarter, focusing on improving profitability and tackling sector-specific challenges.

Key Takeaways

• ATS reported a 17% decline in Q2 revenue year-over-year, totaling $613 million.
• Life Sciences reached record bookings of $742 million.
• The company completed acquisitions of Paxiom and Heidolph to enhance its offerings in food, beverage, and life sciences.
• Q3 revenue projections are between $620 million and $680 million.
• ATS removed $150 million from its backlog relating to EV sales, reflecting reduced growth.
• The focus is on margin expansion and restructuring the transportation segment.

Company Outlook

• ATS expects Q3 revenue between $620 million and $680 million.
• The firm aims for 15% EBITDA margin by Q4 2023, dependent on business performance.

Bearish Highlights

• The transportation sector's decline led to significant revenue decreases.
• The net debt to adjusted EBITDA ratio is at 3.4 times, above the target range.
• An ongoing dispute with an EV customer affects collection on overdue receivables totaling $155 million.
• Cash flows used in operating activities totaled $44.8 million.

Bullish Highlights

• Strong order backlog visibility, especially in Life Sciences, increased 32% year-over-year.
• Life Sciences now constitutes over 60% of the backlog.
• Gross EV bookings were over $30 million for the quarter due to improved contract terms.
• Gross margin improved by approximately 123 basis points year-over-year.

Misses

• Revenue decline due to lower transportation sector sales.
• Adjusted earnings from operations fell 43% to $57 million.
• The company incurred $17.1 million in restructuring costs for the transportation segment.

Q&A Highlights

• Ryan McLeod confirmed anticipated growth in other market verticals excluding transportation, with a book-to-bill ratio of 1.2.
• The food and beverage segment saw a decline but is expected to normalize in Q3 2023.
• ATS focuses strategically on high-value sectors and right-sizing the business.

Overall, ATS Corporation remains optimistic, focusing on strategic acquisitions and high-value segments such as life sciences and food to drive future growth and profitability. The next earnings call is set for February 2024 for Q3 updates and performance insights.